Global Embolization Particle Market Growth 2025-2031

Publication ID:

LPI03253996

Publication Date:

March 24, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Embolization Particle market size is predicted to grow from US$ 2912 million in 2025 to US$ 6751 million in 2031; it is expected to grow at a CAGR of 15.0% from 2025 to 2031.
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
North America is the largest region of Embolization Particle, with a market share about 40%. It was followed by Europe with 30%. Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.
The 鈥淓mbolization Particle Industry Forecast鈥� looks at past sales and reviews total world Embolization Particle sales in 2024, providing a comprehensive analysis by region and market sector of projected Embolization Particle sales for 2025 through 2031. With Embolization Particle sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Embolization Particle industry.
This Insight Report provides a comprehensive analysis of the global Embolization Particle landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Embolization Particle portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Embolization Particle market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Embolization Particle and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Embolization Particle.
This report presents a comprehensive overview, market shares, and growth opportunities of Embolization Particle market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Microspheres
Particles (e.g. PVA Particles, Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Segmentation by Application:
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials B.V.
Alicon
Key Questions Addressed in this Report
What is the 10-year outlook for the global Embolization Particle market?
What factors are driving Embolization Particle market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Embolization Particle market opportunities vary by end market size?
How does Embolization Particle break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Embolization Particle Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Embolization Particle by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Embolization Particle by Country/Region, 2020, 2024 & 2031
2.2 Embolization Particle Segment by Type
2.2.1 Microspheres
2.2.2 Particles (e.g. PVA Particles, Gelfoam Particles)
2.2.3 Drug-eluting Beads (DEBs)
2.2.4 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
2.3 Embolization Particle Sales by Type
2.3.1 Global Embolization Particle Sales Market Share by Type (2020-2025)
2.3.2 Global Embolization Particle Revenue and Market Share by Type (2020-2025)
2.3.3 Global Embolization Particle Sale Price by Type (2020-2025)
2.4 Embolization Particle Segment by Application
2.4.1 Uterine Fibroid Embolization
2.4.2 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
2.4.3 Liver Tumor Embolization
2.4.4 Trauma Embolization
2.4.5 Others
2.5 Embolization Particle Sales by Application
2.5.1 Global Embolization Particle Sale Market Share by Application (2020-2025)
2.5.2 Global Embolization Particle Revenue and Market Share by Application (2020-2025)
2.5.3 Global Embolization Particle Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Embolization Particle Breakdown Data by Company
3.1.1 Global Embolization Particle Annual Sales by Company (2020-2025)
3.1.2 Global Embolization Particle Sales Market Share by Company (2020-2025)
3.2 Global Embolization Particle Annual Revenue by Company (2020-2025)
3.2.1 Global Embolization Particle Revenue by Company (2020-2025)
3.2.2 Global Embolization Particle Revenue Market Share by Company (2020-2025)
3.3 Global Embolization Particle Sale Price by Company
3.4 Key Manufacturers Embolization Particle Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Embolization Particle Product Location Distribution
3.4.2 Players Embolization Particle Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Embolization Particle by Geographic Region
4.1 World Historic Embolization Particle Market Size by Geographic Region (2020-2025)
4.1.1 Global Embolization Particle Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Embolization Particle Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Embolization Particle Market Size by Country/Region (2020-2025)
4.2.1 Global Embolization Particle Annual Sales by Country/Region (2020-2025)
4.2.2 Global Embolization Particle Annual Revenue by Country/Region (2020-2025)
4.3 Americas Embolization Particle Sales Growth
4.4 APAC Embolization Particle Sales Growth
4.5 Europe Embolization Particle Sales Growth
4.6 Middle East & Africa Embolization Particle Sales Growth
5 Americas
5.1 Americas Embolization Particle Sales by Country
5.1.1 Americas Embolization Particle Sales by Country (2020-2025)
5.1.2 Americas Embolization Particle Revenue by Country (2020-2025)
5.2 Americas Embolization Particle Sales by Type (2020-2025)
5.3 Americas Embolization Particle Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Embolization Particle Sales by Region
6.1.1 APAC Embolization Particle Sales by Region (2020-2025)
6.1.2 APAC Embolization Particle Revenue by Region (2020-2025)
6.2 APAC Embolization Particle Sales by Type (2020-2025)
6.3 APAC Embolization Particle Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Embolization Particle by Country
7.1.1 Europe Embolization Particle Sales by Country (2020-2025)
7.1.2 Europe Embolization Particle Revenue by Country (2020-2025)
7.2 Europe Embolization Particle Sales by Type (2020-2025)
7.3 Europe Embolization Particle Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Embolization Particle by Country
8.1.1 Middle East & Africa Embolization Particle Sales by Country (2020-2025)
8.1.2 Middle East & Africa Embolization Particle Revenue by Country (2020-2025)
8.2 Middle East & Africa Embolization Particle Sales by Type (2020-2025)
8.3 Middle East & Africa Embolization Particle Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Embolization Particle
10.3 Manufacturing Process Analysis of Embolization Particle
10.4 Industry Chain Structure of Embolization Particle
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Embolization Particle Distributors
11.3 Embolization Particle Customer
12 World Forecast Review for Embolization Particle by Geographic Region
12.1 Global Embolization Particle Market Size Forecast by Region
12.1.1 Global Embolization Particle Forecast by Region (2026-2031)
12.1.2 Global Embolization Particle Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Embolization Particle Forecast by Type (2026-2031)
12.7 Global Embolization Particle Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Sirtex Medical
13.1.1 Sirtex Medical Company Information
13.1.2 Sirtex Medical Embolization Particle Product Portfolios and Specifications
13.1.3 Sirtex Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sirtex Medical Main Business Overview
13.1.5 Sirtex Medical Latest Developments
13.2 Merit Medical
13.2.1 Merit Medical Company Information
13.2.2 Merit Medical Embolization Particle Product Portfolios and Specifications
13.2.3 Merit Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merit Medical Main Business Overview
13.2.5 Merit Medical Latest Developments
13.3 Cook Medical
13.3.1 Cook Medical Company Information
13.3.2 Cook Medical Embolization Particle Product Portfolios and Specifications
13.3.3 Cook Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Cook Medical Main Business Overview
13.3.5 Cook Medical Latest Developments
13.4 BTG Medical
13.4.1 BTG Medical Company Information
13.4.2 BTG Medical Embolization Particle Product Portfolios and Specifications
13.4.3 BTG Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 BTG Medical Main Business Overview
13.4.5 BTG Medical Latest Developments
13.5 Boston Scientific Corporation
13.5.1 Boston Scientific Corporation Company Information
13.5.2 Boston Scientific Corporation Embolization Particle Product Portfolios and Specifications
13.5.3 Boston Scientific Corporation Embolization Particle Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Boston Scientific Corporation Main Business Overview
13.5.5 Boston Scientific Corporation Latest Developments
13.6 Terumo Corporation
13.6.1 Terumo Corporation Company Information
13.6.2 Terumo Corporation Embolization Particle Product Portfolios and Specifications
13.6.3 Terumo Corporation Embolization Particle Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Terumo Corporation Main Business Overview
13.6.5 Terumo Corporation Latest Developments
13.7 HENGRUI Medical
13.7.1 HENGRUI Medical Company Information
13.7.2 HENGRUI Medical Embolization Particle Product Portfolios and Specifications
13.7.3 HENGRUI Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 HENGRUI Medical Main Business Overview
13.7.5 HENGRUI Medical Latest Developments
13.8 INterface BIOmaterials B.V.
13.8.1 INterface BIOmaterials B.V. Company Information
13.8.2 INterface BIOmaterials B.V. Embolization Particle Product Portfolios and Specifications
13.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 INterface BIOmaterials B.V. Main Business Overview
13.8.5 INterface BIOmaterials B.V. Latest Developments
13.9 Alicon
13.9.1 Alicon Company Information
13.9.2 Alicon Embolization Particle Product Portfolios and Specifications
13.9.3 Alicon Embolization Particle Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Alicon Main Business Overview
13.9.5 Alicon Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂